- Home
- AOS vs MEDP Comparison
AOS vs MEDP Comparison
Compare AOS & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AOS
- MEDP
- Stock Information
- Founded
- AOS 1874
- MEDP 1992
- Country
- AOS United States
- MEDP United States
- Employees
- AOS N/A
- MEDP N/A
- Industry
- AOS Industrial Machinery/Components
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- AOS Industrials
- MEDP Health Care
- Exchange
- AOS Nasdaq
- MEDP Nasdaq
- Market Cap
- AOS 9.8B
- MEDP 10.5B
- IPO Year
- AOS N/A
- MEDP 2016
- Fundamental
- Price
- AOS $65.27
- MEDP $294.00
- Analyst Decision
- AOS Buy
- MEDP Buy
- Analyst Count
- AOS 7
- MEDP 10
- Target Price
- AOS $80.86
- MEDP $373.22
- AVG Volume (30 Days)
- AOS 1.4M
- MEDP 384.3K
- Earning Date
- AOS 04-24-2025
- MEDP 04-21-2025
- Dividend Yield
- AOS 2.07%
- MEDP N/A
- EPS Growth
- AOS N/A
- MEDP 42.23
- EPS
- AOS 3.63
- MEDP 12.63
- Revenue
- AOS $3,818,100,000.00
- MEDP $2,109,054,000.00
- Revenue This Year
- AOS $1.52
- MEDP $4.64
- Revenue Next Year
- AOS $4.90
- MEDP $9.74
- P/E Ratio
- AOS $18.07
- MEDP $24.73
- Revenue Growth
- AOS N/A
- MEDP 11.84
- 52 Week Low
- AOS $64.55
- MEDP $302.01
- 52 Week High
- AOS $92.45
- MEDP $459.77
- Technical
- Relative Strength Index (RSI)
- AOS 39.66
- MEDP 40.74
- Support Level
- AOS $65.94
- MEDP $314.00
- Resistance Level
- AOS $68.02
- MEDP $331.24
- Average True Range (ATR)
- AOS 1.24
- MEDP 8.84
- MACD
- AOS -0.15
- MEDP -0.39
- Stochastic Oscillator
- AOS 6.42
- MEDP 18.32
About AOS A.O. Smith Corporation
A.O. Smith manufactures a broad lineup of water heaters, boilers, and water treatment products. The company has two reporting segments: North America (75% of sales) and rest of world (25% of sales). A.O. Smith is the leading manufacturer of water heaters in North America for the residential and commercial markets, with approximately 37% and 54% market share, respectively. Residential water heaters account for Most of North American sales and are distributed equally through wholesale and retail channels. Most of A.O. Smith's international revenue is from China, a market the company entered during the mid-1990s.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.